IBEX's CEO to Present at Bio CEO and Investor Conference.MONTREAL -- IBEX ibex (ī`bĕks), wild goat, genus Capra, found in rugged country on mountain ranges from central Asia to the Himalayas, S Europe, and NE Africa. Technologies Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :IBT (1) (Instructor Based Training) Training courses conducted by human teachers. (2) (Internet Based Training) Training courses provided via the Internet. ), an innovator in the development of therapeutics and diagnostics for the management of cancer and arthritis, today announced that Paul Baehr, President, Chief Executive Officer and Chairman, will be presenting at the 8th Annual BIO CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. & Investor Conference in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. (February 14-15, 2006) at the Waldorf Astoria Hotel. Mr. Baehr will present on Wednesday, February 15, 2006, at 2:30 p.m. in the Duke of Windsor Room and will be available for one-on-one meetings during the conference. Mr. Baehr's presentation will be webcast live and available for replay via the Company's website at www.ibex.ca. The 8th Annual BIO CEO & Investor Conference, one of the year's largest life science investor events, provides a forum for private and public companies to present progress on their development programs to investors and the financial community. About IBEX IBEX is focused on the development of therapeutics and diagnostics for the management of cancer and arthritis. The Company's cancer program is based on a novel family of genes known as kallikreins.IBEX is exploring the role of kallikreins in metastatic Metastatic The term used to describe a secondary cancer, or one that has spread from one area of the body to another. Mentioned in: Coagulation Disorders metastatic pertaining to or of the nature of a metastasis. disease to use as potential therapeutic applications. Additionally, IBEX is developing kallikrein-based diagnostics for the screening and monitoring of cancer. The Company's arthritis program is based on a series of biomarkers of cartilage degradation and synthesis. IBEX markets a number of products, including its proprietary enzymes (heparinases and chondroitinases), as well as a series of arthritis and kallikrein-based assays. IBEX(TM) Heparinase I is used in many leading hemostasis hemostasis /he·mo·sta·sis/ (he?mo-sta´sis) (he-mos´tah-sis) 1. the arrest of bleeding by the physiological properties of vasoconstriction and coagulation or by surgical means. 2. monitoring devices, while IBEX arthritis assays are used by leading pharmaceutical companies for research purposes. For more information about BIO CEO visit http://ceo.bio.org/opencms/ceo/2006/index.jsp Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement All of the statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the pharmaceutical industry, changes in the regulatory environment in the jurisdictions in which IBEX does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. IBEX disclaims any intention or obligation to update these statements. IBEX TECHNOLOGIES INC. (TSX:IBT) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion